Literature DB >> 17132477

Repair of obstetric vesicovaginal fistulas in Africa.

Marcella L Roenneburg1, Rene Genadry, Clifford R Wheeless.   

Abstract

OBJECTIVE: The purpose of this study was to show the outcomes of primary surgical repair of obstetric vesicovaginal fistula repairs in Niger, Africa. STUDY
DESIGN: From October 2003 to April 2005, 90 patients were examined with vesicovaginal fistulas and no previous repair. Fistulas were variable in location and degree of scarring and ranged up to 7 cm in size. All patients were offered surgical repair. Primary repair was performed in 73 women.
RESULTS: Successful primary closure was achieved in 41 patients (56%); 19 patients were lost to follow up, and 13 patients had a persistent fistula. Incontinence, despite fistula closure, was present in 9 patients. Common features of failure and/or incontinence included larger size, involvement of the urethrovesical junction, and scarring.
CONCLUSION: The initial repair of vesicovaginal fistulas has the highest probability of success. The successful closure is dependent on size, site, and associated scarring.

Entities:  

Mesh:

Year:  2006        PMID: 17132477     DOI: 10.1016/j.ajog.2006.07.031

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

1.  Comparison of two classification systems for vesicovaginal fistula.

Authors:  T Capes; E J Stanford; L Romanzi; Y Foma; E Moshier
Journal:  Int Urogynecol J       Date:  2012-01-25       Impact factor: 2.894

2.  High loss to follow-up following obstetric fistula repair surgery in rural Burundi: is there a way forward?

Authors:  A Bishinga; R Zachariah; S Hinderaker; K Tayler-Smith; M Khogali; J van Griensven; W van den Boogaard; M Tamura; B Christiaens; G Sinabajije
Journal:  Public Health Action       Date:  2013-06-21

3.  Association between parity and fistula location in women with obstetric fistula: a multivariate regression analysis.

Authors:  A M Sih; D M Kopp; J H Tang; N E Rosenberg; E Chipungu; M Harfouche; M Moyo; M Mwale; J P Wilkinson
Journal:  BJOG       Date:  2016-02-08       Impact factor: 6.531

4.  Factors Influencing Post-Operative Short-Term Outcomes of Vesicovaginal Fistula Repairs in a Community Hospital in Liberia.

Authors:  Oxana Munoz; C Bryce Bowling; Kimberly A Gerten; Rebecca Taryor; Andy M Norman; Jeff M Szychowski; Holly E Richter
Journal:  Br J Med Surg Urol       Date:  2011-11

5.  Obstetric fistula: living with incontinence and shame.

Authors:  Luwam Semere; Nawal M Nour
Journal:  Rev Obstet Gynecol       Date:  2008

Review 6.  Current techniques for vesicovaginal fistula repair: surgical pearls to optimize cure rate.

Authors:  Brian L Cohen; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

7.  Predictors and outcome of surgical repair of obstetric fistula at a regional referral hospital, Mbarara, western Uganda.

Authors:  Musa Kayondo; Ssalongo Wasswa; Jerome Kabakyenga; Nozmo Mukiibi; Jude Senkungu; Amy Stenson; Peter Mukasa
Journal:  BMC Urol       Date:  2011-12-07       Impact factor: 2.264

8.  Characteristics of obstetric fistulas and the need for a prognostic classification system.

Authors:  Ates Karateke; Cetin Cam; Arman Ozdemir; Buhara Guney; Dogan Vatansever; Cem Celik
Journal:  Arch Med Sci       Date:  2010-04-30       Impact factor: 3.318

9.  "I am alone and isolated": a qualitative study of experiences of women living with genital fistula in Uganda.

Authors:  Justus Kafunjo Barageine; Jolly Beyeza-Kashesya; Josaphat K Byamugisha; Nazarius Mbona Tumwesigye; Lars Almroth; Elisabeth Faxelid
Journal:  BMC Womens Health       Date:  2015-09-10       Impact factor: 2.809

Review 10.  Obstetric fistula in low-resource countries: an under-valued and under-studied problem--systematic review of its incidence, prevalence, and association with stillbirth.

Authors:  Karen D Cowgill; Jennifer Bishop; Amanda K Norgaard; Craig E Rubens; Michael G Gravett
Journal:  BMC Pregnancy Childbirth       Date:  2015-08-26       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.